The 2nd Annual MarketsandMarkets Minimally Invasive Surgery Conference is gearing up to host a stellar collection of surgeons, doctors & researchers across 6 different streams of surgery namely, Urology, Colorectal, Hip & Knee, Gynaecology, Bariatric, Sports Medicine & Spinal Surgery.With over 60+ speakers sharing enriching insights through their decades of experience, we cannot wait for them to showcase their presentations on the 14th – 15th of September in London, UK. In the build-up to the conference, we sat down for a quick chat with ‘Professor Paul Lee‘, who founded ‘MSK…
Read MoreTag: regenerative medicine
Speaker Interview with Fabio D’Agostino for 4th Annual MarketsandMarkets Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine Congress
London, January 07 – MarketsandMarkets interviewed Fabio D’Agostino,Venture Partner, Claris Ventures regarding 4th Annual MarketsandMarkets Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine Congress taking place on 10-11 March 2020 in London – UK. Q. What is the most trending areas of cellular therapies currently? A. CART and NK cell Q. What are the recent developments and technological advancements? A. CART for solid tumors and NK CAR Q. What are the key take away points from your presentation? A. They are basically summarized in my bullet points. I will…
Read MoreSpeaker Interview with Karin Jennbacken for 4th Annual MarketsandMarkets Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine Congress
London, December 13 – MarketsandMarkets interviewed Karin Jennbacken, Team Leader, Heart Failure in vitro team, AstraZeneca regarding 4th Annual MarketsandMarkets Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine Congress taking place on 10-11 March 2020 in London – UK. Dr Jennbacken’s team is responsible for target discovery and early development of therapeutics for treatment of patients with cardiovascular disease. Q. What is the most trending areas of cellular therapies currently? A. Cardiac therapies using pluripotent stem cells is where most of the researches are going on. Q. What are the…
Read MoreSpeaker Interview with Petter Björquist for 4th Annual MarketsandMarkets Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine Congress
London, December 13 – MarketsandMarkets interviewed Petter Björquist, CEO, Verigraft regarding 4th Annual MarketsandMarkets Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine Congress taking place on 10-11 March 2020 in London – UK. Petter Björquist is a PhD in Biology/Biochemistry from Gothenburg University, 50 + publications in peer reviewed journals, several book chapters and patents. Q. What is the most trending areas of cellular therapies currently? A. I would say that is 1) CAR T-cell Therapy. This field has exploded, and started a new era in cancer treatment. 2) Genome…
Read More